▶ 調査レポート

世界のスプリング式ニードルフリーインジェクター市場(~2028年):液体注射用無針注射器、粉末注射用無針注射器、飛翔体注射用無針注射器

• 英文タイトル:Global Spring-loaded Needle-Free Injectors Market Insights, Forecast to 2028

Global Spring-loaded Needle-Free Injectors Market Insights, Forecast to 2028「世界のスプリング式ニードルフリーインジェクター市場(~2028年):液体注射用無針注射器、粉末注射用無針注射器、飛翔体注射用無針注射器」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2Q12-18463
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:医療機器&消耗品
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、スプリング式ニードルフリーインジェクターのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
スプリング式ニードルフリーインジェクターのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
スプリング式ニードルフリーインジェクターの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
スプリング式ニードルフリーインジェクターのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までのスプリング式ニードルフリーインジェクターの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のスプリング式ニードルフリーインジェクターの売上および2028年までの予測に焦点を当てています。

スプリング式ニードルフリーインジェクターのグローバル主要企業には、Gerresheimer、Pfizer、Halozyme、CSL Limited (Seqirus UK Limited)、Crossject、Portal Instruments、Ferring Pharmaceuticals、PharmaJet、PenJet Corporationなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

スプリング式ニードルフリーインジェクター市場は、タイプとアプリケーションによって区分されます。世界のスプリング式ニードルフリーインジェクター市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
液体注射用無針注射器、粉末注射用無針注射器、飛翔体注射用無針注射器

【アプリケーション別セグメント】
在宅介護施設、介護施設

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- スプリング式ニードルフリーインジェクター製品概要
- タイプ別市場(液体注射用無針注射器、粉末注射用無針注射器、飛翔体注射用無針注射器)
- アプリケーション別市場(在宅介護施設、介護施設)
- 調査の目的
・エグゼクティブサマリー
- 世界のスプリング式ニードルフリーインジェクター販売量予測2017-2028
- 世界のスプリング式ニードルフリーインジェクター売上予測2017-2028
- スプリング式ニードルフリーインジェクターの地域別販売量
- スプリング式ニードルフリーインジェクターの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別スプリング式ニードルフリーインジェクター販売量
- 主要メーカー別スプリング式ニードルフリーインジェクター売上
- 主要メーカー別スプリング式ニードルフリーインジェクター価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模(液体注射用無針注射器、粉末注射用無針注射器、飛翔体注射用無針注射器)
- スプリング式ニードルフリーインジェクターのタイプ別販売量
- スプリング式ニードルフリーインジェクターのタイプ別売上
- スプリング式ニードルフリーインジェクターのタイプ別価格
・アプリケーション別市場規模(在宅介護施設、介護施設)
- スプリング式ニードルフリーインジェクターのアプリケーション別販売量
- スプリング式ニードルフリーインジェクターのアプリケーション別売上
- スプリング式ニードルフリーインジェクターのアプリケーション別価格
・北米市場
- 北米のスプリング式ニードルフリーインジェクター市場規模(タイプ別、アプリケーション別)
- 主要国別のスプリング式ニードルフリーインジェクター市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのスプリング式ニードルフリーインジェクター市場規模(タイプ別、アプリケーション別)
- 主要国別のスプリング式ニードルフリーインジェクター市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のスプリング式ニードルフリーインジェクター市場規模(タイプ別、アプリケーション別)
- 主要国別のスプリング式ニードルフリーインジェクター市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のスプリング式ニードルフリーインジェクター市場規模(タイプ別、アプリケーション別)
- 主要国別のスプリング式ニードルフリーインジェクター市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのスプリング式ニードルフリーインジェクター市場規模(タイプ別、アプリケーション別)
- 主要国別のスプリング式ニードルフリーインジェクター市場規模(トルコ、サウジアラビア)
・企業情報
Gerresheimer、Pfizer、Halozyme、CSL Limited (Seqirus UK Limited)、Crossject、Portal Instruments、Ferring Pharmaceuticals、PharmaJet、PenJet Corporation
・産業チェーン及び販売チャネル分析
- スプリング式ニードルフリーインジェクターの産業チェーン分析
- スプリング式ニードルフリーインジェクターの原材料
- スプリング式ニードルフリーインジェクターの生産プロセス
- スプリング式ニードルフリーインジェクターの販売及びマーケティング
- スプリング式ニードルフリーインジェクターの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- スプリング式ニードルフリーインジェクターの産業動向
- スプリング式ニードルフリーインジェクターのマーケットドライバー
- スプリング式ニードルフリーインジェクターの課題
- スプリング式ニードルフリーインジェクターの阻害要因
・主な調査結果

Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Spring-loaded Needle-Free Injectors is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Spring-loaded Needle-Free Injectors is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Spring-loaded Needle-Free Injectors is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Spring-loaded Needle-Free Injectors include Gerresheimer, Pfizer, Halozyme, CSL Limited (Seqirus UK Limited), Crossject, Portal Instruments, Ferring Pharmaceuticals, PharmaJet and PenJet Corporation, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Spring-loaded Needle-Free Injectors manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Spring-loaded Needle-Free Injectors market. Further, it explains the major drivers and regional dynamics of the global Spring-loaded Needle-Free Injectors market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Gerresheimer
Pfizer
Halozyme
CSL Limited (Seqirus UK Limited)
Crossject
Portal Instruments
Ferring Pharmaceuticals
PharmaJet
PenJet Corporation
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Spring-loaded Needle-Free Injectors Segment by Type
Needle-Free Injectors by Liquid Injections
Needle-Free Injectors by Powder Injections
Needle-Free Injectors by Projectile Injections
Spring-loaded Needle-Free Injectors Segment by Application
Home Care Settings
Long Term Care Centers
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Spring-loaded Needle-Free Injectors market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Spring-loaded Needle-Free Injectors, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Spring-loaded Needle-Free Injectors, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Spring-loaded Needle-Free Injectors, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Spring-loaded Needle-Free Injectors sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Spring-loaded Needle-Free Injectors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Spring-loaded Needle-Free Injectors sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Gerresheimer, Pfizer, Halozyme, CSL Limited (Seqirus UK Limited), Crossject, Portal Instruments, Ferring Pharmaceuticals, PharmaJet and PenJet Corporation, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Spring-loaded Needle-Free Injectors in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Spring-loaded Needle-Free Injectors manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Spring-loaded Needle-Free Injectors sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

レポート目次

1 Study Coverage
1.1 Spring-loaded Needle-Free Injectors Product Introduction
1.2 Market by Type
1.2.1 Global Spring-loaded Needle-Free Injectors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Needle-Free Injectors by Liquid Injections
1.2.3 Needle-Free Injectors by Powder Injections
1.2.4 Needle-Free Injectors by Projectile Injections
1.3 Market by Application
1.3.1 Global Spring-loaded Needle-Free Injectors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Home Care Settings
1.3.3 Long Term Care Centers
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Spring-loaded Needle-Free Injectors Sales Estimates and Forecasts 2017-2028
2.2 Global Spring-loaded Needle-Free Injectors Revenue Estimates and Forecasts 2017-2028
2.3 Global Spring-loaded Needle-Free Injectors Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Spring-loaded Needle-Free Injectors Sales by Region
2.4.1 Global Spring-loaded Needle-Free Injectors Sales by Region (2017-2022)
2.4.2 Global Sales Spring-loaded Needle-Free Injectors by Region (2023-2028)
2.5 Global Spring-loaded Needle-Free Injectors Revenue by Region
2.5.1 Global Spring-loaded Needle-Free Injectors Revenue by Region (2017-2022)
2.5.2 Global Spring-loaded Needle-Free Injectors Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Spring-loaded Needle-Free Injectors Sales by Manufacturers
3.1.1 Global Top Spring-loaded Needle-Free Injectors Manufacturers by Sales (2017-2022)
3.1.2 Global Spring-loaded Needle-Free Injectors Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Spring-loaded Needle-Free Injectors in 2021
3.2 Global Spring-loaded Needle-Free Injectors Revenue by Manufacturers
3.2.1 Global Spring-loaded Needle-Free Injectors Revenue by Manufacturers (2017-2022)
3.2.2 Global Spring-loaded Needle-Free Injectors Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Spring-loaded Needle-Free Injectors Revenue in 2021
3.3 Global Spring-loaded Needle-Free Injectors Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Spring-loaded Needle-Free Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Spring-loaded Needle-Free Injectors Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Spring-loaded Needle-Free Injectors Sales by Type
4.1.1 Global Spring-loaded Needle-Free Injectors Historical Sales by Type (2017-2022)
4.1.2 Global Spring-loaded Needle-Free Injectors Forecasted Sales by Type (2023-2028)
4.1.3 Global Spring-loaded Needle-Free Injectors Sales Market Share by Type (2017-2028)
4.2 Global Spring-loaded Needle-Free Injectors Revenue by Type
4.2.1 Global Spring-loaded Needle-Free Injectors Historical Revenue by Type (2017-2022)
4.2.2 Global Spring-loaded Needle-Free Injectors Forecasted Revenue by Type (2023-2028)
4.2.3 Global Spring-loaded Needle-Free Injectors Revenue Market Share by Type (2017-2028)
4.3 Global Spring-loaded Needle-Free Injectors Price by Type
4.3.1 Global Spring-loaded Needle-Free Injectors Price by Type (2017-2022)
4.3.2 Global Spring-loaded Needle-Free Injectors Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Spring-loaded Needle-Free Injectors Sales by Application
5.1.1 Global Spring-loaded Needle-Free Injectors Historical Sales by Application (2017-2022)
5.1.2 Global Spring-loaded Needle-Free Injectors Forecasted Sales by Application (2023-2028)
5.1.3 Global Spring-loaded Needle-Free Injectors Sales Market Share by Application (2017-2028)
5.2 Global Spring-loaded Needle-Free Injectors Revenue by Application
5.2.1 Global Spring-loaded Needle-Free Injectors Historical Revenue by Application (2017-2022)
5.2.2 Global Spring-loaded Needle-Free Injectors Forecasted Revenue by Application (2023-2028)
5.2.3 Global Spring-loaded Needle-Free Injectors Revenue Market Share by Application (2017-2028)
5.3 Global Spring-loaded Needle-Free Injectors Price by Application
5.3.1 Global Spring-loaded Needle-Free Injectors Price by Application (2017-2022)
5.3.2 Global Spring-loaded Needle-Free Injectors Price Forecast by Application (2023-2028)
6 North America
6.1 North America Spring-loaded Needle-Free Injectors Market Size by Type
6.1.1 North America Spring-loaded Needle-Free Injectors Sales by Type (2017-2028)
6.1.2 North America Spring-loaded Needle-Free Injectors Revenue by Type (2017-2028)
6.2 North America Spring-loaded Needle-Free Injectors Market Size by Application
6.2.1 North America Spring-loaded Needle-Free Injectors Sales by Application (2017-2028)
6.2.2 North America Spring-loaded Needle-Free Injectors Revenue by Application (2017-2028)
6.3 North America Spring-loaded Needle-Free Injectors Market Size by Country
6.3.1 North America Spring-loaded Needle-Free Injectors Sales by Country (2017-2028)
6.3.2 North America Spring-loaded Needle-Free Injectors Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Spring-loaded Needle-Free Injectors Market Size by Type
7.1.1 Europe Spring-loaded Needle-Free Injectors Sales by Type (2017-2028)
7.1.2 Europe Spring-loaded Needle-Free Injectors Revenue by Type (2017-2028)
7.2 Europe Spring-loaded Needle-Free Injectors Market Size by Application
7.2.1 Europe Spring-loaded Needle-Free Injectors Sales by Application (2017-2028)
7.2.2 Europe Spring-loaded Needle-Free Injectors Revenue by Application (2017-2028)
7.3 Europe Spring-loaded Needle-Free Injectors Market Size by Country
7.3.1 Europe Spring-loaded Needle-Free Injectors Sales by Country (2017-2028)
7.3.2 Europe Spring-loaded Needle-Free Injectors Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Spring-loaded Needle-Free Injectors Market Size by Type
8.1.1 Asia Pacific Spring-loaded Needle-Free Injectors Sales by Type (2017-2028)
8.1.2 Asia Pacific Spring-loaded Needle-Free Injectors Revenue by Type (2017-2028)
8.2 Asia Pacific Spring-loaded Needle-Free Injectors Market Size by Application
8.2.1 Asia Pacific Spring-loaded Needle-Free Injectors Sales by Application (2017-2028)
8.2.2 Asia Pacific Spring-loaded Needle-Free Injectors Revenue by Application (2017-2028)
8.3 Asia Pacific Spring-loaded Needle-Free Injectors Market Size by Region
8.3.1 Asia Pacific Spring-loaded Needle-Free Injectors Sales by Region (2017-2028)
8.3.2 Asia Pacific Spring-loaded Needle-Free Injectors Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Spring-loaded Needle-Free Injectors Market Size by Type
9.1.1 Latin America Spring-loaded Needle-Free Injectors Sales by Type (2017-2028)
9.1.2 Latin America Spring-loaded Needle-Free Injectors Revenue by Type (2017-2028)
9.2 Latin America Spring-loaded Needle-Free Injectors Market Size by Application
9.2.1 Latin America Spring-loaded Needle-Free Injectors Sales by Application (2017-2028)
9.2.2 Latin America Spring-loaded Needle-Free Injectors Revenue by Application (2017-2028)
9.3 Latin America Spring-loaded Needle-Free Injectors Market Size by Country
9.3.1 Latin America Spring-loaded Needle-Free Injectors Sales by Country (2017-2028)
9.3.2 Latin America Spring-loaded Needle-Free Injectors Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Spring-loaded Needle-Free Injectors Market Size by Type
10.1.1 Middle East and Africa Spring-loaded Needle-Free Injectors Sales by Type (2017-2028)
10.1.2 Middle East and Africa Spring-loaded Needle-Free Injectors Revenue by Type (2017-2028)
10.2 Middle East and Africa Spring-loaded Needle-Free Injectors Market Size by Application
10.2.1 Middle East and Africa Spring-loaded Needle-Free Injectors Sales by Application (2017-2028)
10.2.2 Middle East and Africa Spring-loaded Needle-Free Injectors Revenue by Application (2017-2028)
10.3 Middle East and Africa Spring-loaded Needle-Free Injectors Market Size by Country
10.3.1 Middle East and Africa Spring-loaded Needle-Free Injectors Sales by Country (2017-2028)
10.3.2 Middle East and Africa Spring-loaded Needle-Free Injectors Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Gerresheimer
11.1.1 Gerresheimer Corporation Information
11.1.2 Gerresheimer Overview
11.1.3 Gerresheimer Spring-loaded Needle-Free Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Gerresheimer Spring-loaded Needle-Free Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Gerresheimer Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Spring-loaded Needle-Free Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Spring-loaded Needle-Free Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Halozyme
11.3.1 Halozyme Corporation Information
11.3.2 Halozyme Overview
11.3.3 Halozyme Spring-loaded Needle-Free Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Halozyme Spring-loaded Needle-Free Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Halozyme Recent Developments
11.4 CSL Limited (Seqirus UK Limited)
11.4.1 CSL Limited (Seqirus UK Limited) Corporation Information
11.4.2 CSL Limited (Seqirus UK Limited) Overview
11.4.3 CSL Limited (Seqirus UK Limited) Spring-loaded Needle-Free Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 CSL Limited (Seqirus UK Limited) Spring-loaded Needle-Free Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 CSL Limited (Seqirus UK Limited) Recent Developments
11.5 Crossject
11.5.1 Crossject Corporation Information
11.5.2 Crossject Overview
11.5.3 Crossject Spring-loaded Needle-Free Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Crossject Spring-loaded Needle-Free Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Crossject Recent Developments
11.6 Portal Instruments
11.6.1 Portal Instruments Corporation Information
11.6.2 Portal Instruments Overview
11.6.3 Portal Instruments Spring-loaded Needle-Free Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Portal Instruments Spring-loaded Needle-Free Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Portal Instruments Recent Developments
11.7 Ferring Pharmaceuticals
11.7.1 Ferring Pharmaceuticals Corporation Information
11.7.2 Ferring Pharmaceuticals Overview
11.7.3 Ferring Pharmaceuticals Spring-loaded Needle-Free Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ferring Pharmaceuticals Spring-loaded Needle-Free Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ferring Pharmaceuticals Recent Developments
11.8 PharmaJet
11.8.1 PharmaJet Corporation Information
11.8.2 PharmaJet Overview
11.8.3 PharmaJet Spring-loaded Needle-Free Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 PharmaJet Spring-loaded Needle-Free Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 PharmaJet Recent Developments
11.9 PenJet Corporation
11.9.1 PenJet Corporation Corporation Information
11.9.2 PenJet Corporation Overview
11.9.3 PenJet Corporation Spring-loaded Needle-Free Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 PenJet Corporation Spring-loaded Needle-Free Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 PenJet Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Spring-loaded Needle-Free Injectors Industry Chain Analysis
12.2 Spring-loaded Needle-Free Injectors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Spring-loaded Needle-Free Injectors Production Mode & Process
12.4 Spring-loaded Needle-Free Injectors Sales and Marketing
12.4.1 Spring-loaded Needle-Free Injectors Sales Channels
12.4.2 Spring-loaded Needle-Free Injectors Distributors
12.5 Spring-loaded Needle-Free Injectors Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Spring-loaded Needle-Free Injectors Industry Trends
13.2 Spring-loaded Needle-Free Injectors Market Drivers
13.3 Spring-loaded Needle-Free Injectors Market Challenges
13.4 Spring-loaded Needle-Free Injectors Market Restraints
14 Key Findings in The Global Spring-loaded Needle-Free Injectors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer